BCL7A and cancer: Thus, our work pinpointing the role of these evolutionarily conserved subunits frequently perturbed in human cancer may suggest exciting therapeutic opportunities for chemically fine-tuning SWI/SNF remodeling activities through targeting BCL7A/B/C proteins.